Cardiologist issues urgent heart warning to anyone thinking of stopping weight-loss jabs

Resumen detallado
It is estimated that more than 1.5million people in the UK are using injections to lose weight
A heart surgeon has warned that people taking weight-loss jabs should think carefully before stopping their treatment, after new research linked coming off the drugs with a higher risk of heart attack, stroke and death. The findings raise fresh questions about what happens when patients stop taking GLP-1 medicines - but experts say they are not proof that ditching the jabs causes heart problems.
Researchers examined the medical records of more than 80,000 people with type 2 diabetes across 301 diabetes clinics in Italy, all of whom had no established cardiovascular disease when the study began. The research, published in The Lancet Regional Health - Europe in November 2026, analysed patient records spanning 2004 to 2024.
The study compared people who stopped taking GLP-1 medication with those who continued treatment. Those who continued used the drugs for nearly three years on average, compared with just over a year among those who stopped. Researchers found that the combined rate of non-fatal heart attack, non-fatal stroke or death from any cause was around twice as high among those who discontinued treatment.
Dr Francesco Lo Monaco, cardiologist and founder of the National Longevity Clinic, said the findings highlight the importance of understanding the potential cardiovascular implications of stopping treatment. He said: "GLP-1 medicines are increasingly being used to manage type 2 diabetes and obesity, and we know that these conditions are closely linked to cardiovascular health.
“These findings are interesting because they suggest that the potential benefits of treatment may extend beyond weight loss and blood sugar control. But we need to be very careful about interpreting them.”
Researchers reported that the combined rate of non-fatal heart attack, non-fatal stroke or death from any cause was around twice as high among those who stopped treatment. The association appeared stronger among people who remained obese after stopping treatment.
Researchers also found…
Dr…
I…
Inicio del artículo, extracto de Daily Mirror. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.mirror.co.uk)





